期刊文献+

钙离子/钙调素依赖性蛋白激酶Ⅱ在大鼠胚胎心肌肥大细胞中调控血管紧张素Ⅱ诱导的细胞自噬 被引量:11

Ca^(2+)/calmodulin-dependent protein kinase Ⅱ regulates cardiac hypertrophy by mediating autophagy
下载PDF
导出
摘要 目的:探讨钙离子/钙调素依赖性蛋白激酶Ⅱ(Ca^(2+)/calmodulin-dependent protein kinase Ⅱ,CaMK Ⅱ)与细胞自噬在胚胎心肌细胞肥大发展过程中的相互作用。方法:使用血管紧张素Ⅱ作用于大鼠胚胎心肌细胞株H9c2细胞,建立体外心肌细胞肥大模型,通过药物抑制和基因过表达及敲除等方法分析细胞自噬通路AMPK-LC3 Ⅱ。结果:血管紧张素Ⅱ可快速诱导CaMKⅡ及细胞自噬相关通路AMPK磷酸化以及细胞自噬标记蛋白LC3 Ⅱ表达,CaMKⅡ抑制剂以及基因敲除和药物抑制CaMK Ⅱ下游因子组蛋白乙酰转移酶4(HDAC4)可显著阻断血管紧张素Ⅱ诱导的LC3 Ⅱ蛋白表达(P<0.05)。结论:CaMK Ⅱ作为心肌肥大病理过程的中心调控子,可以通过AMPK或其下游HDAC4直接或间接调控细胞自噬,进而调节心肌肥大的发生发展。 Objective To elucidate the relationship between Ca2+/calmodulin?dependent protein kinaseⅡ(CaMKⅡ)and autophagy during the development of cardiac hypertrophy.Methods Rat embryonic cardiac cellline H9c2cells was treated by angiotensinⅡto establish cardiomyocyte hypertrophy model in vitro and usingantagonists and gene function gain and loss to analyze AMPK?LC3Ⅱautophagy signaling pathway.Results Thephosphorylation of CaMKⅡand autophagy related signaling?AMPK and autophagy marker LC3Ⅱwere rapidlyincreased by angiotensinⅡtreatment at early stage.However,the above changes were highly blocked by CaMKⅡinhibitor and HDAC4inhibition.Conclusion CaMKⅡis the center factor of regulating cardiac hypertrophy,itmediates autophagy through directly regulating AMPK or indirectly regulating HDAC4during the development ofcardiac hypertrophy.
作者 罗敏 张慧蓉 赵玲 LUO Min;ZHANG Huirong;ZHAO Ling(General Hospital of Guangzhou Military Command of PLA,Guangzhou 510010,China)
出处 《实用医学杂志》 CAS 北大核心 2017年第12期1917-1922,共6页 The Journal of Practical Medicine
基金 广东省自然科学基金项目(编号:2016A030313616) 广州市科技计划项目(编号:201607010184)
关键词 心肌细胞肥大 细胞自噬 钙离子/钙调素依赖性蛋白激酶Ⅱ AMPK LC3II Cardiac hypertrophy Autophagy Ca2+/calmodulin.dependent protein kinase Ⅱ AMPK LC3Ⅱ
  • 相关文献

参考文献3

二级参考文献16

  • 1邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 2Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality [J]. Curr Opin Obstet Gyneeol, 2013, 25(2): 124-132.
  • 3Sibai BM. Diagnosis, prevention and management of eelampsia[J].ObstetGynecol, 2005, 105(2): 402-410.
  • 4Moura MD, Margotto PR, Rugolo LM. Changes of blood flow in the umbilical artery in hypertensive pregnancy and the implications in the neonatal outcomes [J]. Rev Bras GinecolObstet, 2013, 35(2): 71-77.
  • 5Masoura S, Kalogiannidis I, Makedou K, et al. Biomar- kers of endothelial dysfunction in preeelampsia and neonatal morbidity: a case-control study [J]. Eur J Obstet Gynecol ReprodBiol, 2014, 175: 119-123.
  • 6Valdes ER, LaRes KA, Mufioz HS, et al. First-trimester adiponecfin and subsequent development ofpreeclampsia or fetal growth restriction [J]. Gynecol Obstet Invest, 2011, 72(3): 152-156.
  • 7Zook KJ, Mackley AB, Kern J, et al. Hematologic effects of placental pathology on very low birthweight in- fants born to mothers with preeclarnpsia [J]. J Perinatol, 2009, 29(1): 8-12.
  • 8Herbstman J, Apelberg BJ, Witter FR, et al. Maternal, infant, and delivery factors associated with neonatal thyroid hormone status [J]. Thyroid, 2008, 18(1): 67-76.
  • 9Chandiramani M, Joash K, Shennan AH. Options and decision-making: hypertensive disorders of pregnancy [J]. Future Cardiol, 2010, 6(4): 535-546.
  • 10孙妍,牛昊书,李俊利,张亚京,周蕊,毛洪刚.脐血瘦素、胰岛素样生长因子-Ⅰ与胎儿生长发育[J].临床儿科杂志,2009,27(6):556-559. 被引量:22

共引文献94

同被引文献49

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部